Sleep symptoms in people with Progressive Supranuclear Palsy in Argentina
Objective: To report sleep features and symptoms in a longitudinal prospective cohort of people with PSP from Argentina (CAITauP cohort). Background: Progressive supranuclear palsy (PSP),…Motor Frailty Index (MFI) as an Early Predictor of Functional Progression in Parkinson’s Disease: A Longitudinal Analysis
Objective: To develop and evaluate a Motor Frailty Index (MFI) based on routine clinical variables as an early predictor of motor progression in persons with…Toward Objective Monitoring of Motor Fluctuations in Parkinson’s Disease: TMS-EEG Biomarkers
Objective: Assess utility of TMS-EEG as objective markers for Motor fluctuations (MF) in Parkinson’s disease (PD). Background: MF in PD are episodic changes in motor…Prevalence and Clinical Determinants of Cognitive Impairment in a Diverse Parkinson’s Disease Cohort
Objective: To estimate the prevalence of cognitive impairment in a diverse Parkinson’s disease (PD) cohort and explore its associations with vascular, motor, and non-motor determinants.…Distinct Cortical and Subcortical Network Mechanisms of High and Low Frequency Subthalamic Stimulation in Parkinsons Disease
Objective: The study aimed to quantify and compare the directional, effective connectivity modulated by HFS and LFS within a motor-cognitive-emotional brain network to identify the…Intestinal Levodopa Infusion Therapies in Advanced Parkinson’s Disease: A 6-Month Prospective Cohort Study
Objective: To evaluate 6-month changes in motor and non-motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel (LCIG) or levodopa/entacapone/carbidopa intestinal…Relationship between automatic analysis of gait disorder and eye movement capture by AI and cognitive function in Parkinson’s disease
Objective: Gait disorder is a hallmark of Parkinson’s disease (PD), with mounting evidence linking gait to cognitive function in PD patients and eye movements serving…Peripheral Inflammatory Markers and Clinical Correlations in Parkinson’s Disease Patients Carrying LRRK2 G2385R and R1628P Variants
Objective: To investigate plasma cytokines and chemokines with clinical correlations between Parkinson’s disease (PD) patients carrying LRRK2 p.G2385R and/or p.R1628P variants, idiopathic PD (iPD), and healthy controls.…MDSGene literature update on autosomal recessive Parkinson’s Disease
Objective: To comprehensively characterize demographic, genetic, and phenotypic features in individuals with autosomal recessive Parkinson’s disease (PD), leveraging individual-level data from published literature. Background: In…Safety and Effectiveness of DaxibotulinumtoxinA in Cervical Dystonia: A Systematic Review and Meta-Analysis of Different Doses
Objective: To evaluate the effectiveness and safety of DaxibotulinumtoxinA (DAXI) in patients diagnosed with cervical dystonia (CD). Background: Botulinum toxins (BoNTs) are the first-line therapy…
- « Previous Page
- 1
- …
- 113
- 114
- 115
- 116
- 117
- …
- 208
- Next Page »